TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
RVTY

Revvity Inc.

Healthcare · Diagnostics & Research

153.60$ +0.2% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

Revvity Inc. (RVTY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 192 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RVTY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
74 149 54 48 59 128 -15 73 93 159 -5.3 47 107 215 60 139 211 482 474 288 314 336 283 97 160 139 63 -135 -33 197 148 159 148 174 128 134 139 183 115 192 629
24 21 25 25 26 29 44 44 45 47 50 53 53 57 61 59 62 64 70 76 52 125 109 109 105 104 109 109 108 106 108 107 108 105 97 103 102 103 105 102 412
3.8 3.3 4.9 6.8 4.4 9.2 5.3 6.8 11 5.5 6.1 6.7 12 6.4 3.1 9.6 7.1 9.4 5.2 7.2 4.4 14 14 15 10 12 9.9 14 11 7.2 12 11 11 5.1 7.7 10 9.1 -4.1 8.7 11 24
– – – – – – – – – – – – – – – – – – – – – – – – -18 -144 -51 -76 -5.6 – – – – – – – – – – – –
-14 37 -38 -43 -62 105 -107 -59 -36 71 -111 -95 -42 84 -33 -71 -43 28 28 -41 64 60 -22 -209 -81 -82 -96 -234 -148 83 -19 -12 -48 61 -13 -49 -16 1.1 -39 -18 -72
9.0 7.3 6.0 5.5 11 17 23 17 21 33 25 17 17 23 20 17 20 20 14 20 24 32 27 20 13 26 21 14 22 24 18 22 22 24 16 19 19 20 20 11 70
-70 -23 -130 272 45 -1,454 -24 -56 8.0 -88 -29 -257 -29 -172 -22 -24 -23 -436 -462 -290 -3,301 -60 -56 -28 -23 -26 -571 -571 435 -415 -18 121 690 -17 -6.4 -9.5 19 -20 -78 -3.5 -83
7.7 7.7 7.7 7.7 7.7 7.7 7.7 7.7 7.8 7.8 7.7 7.8 7.8 7.8 7.8 7.8 7.8 7.8 7.9 7.8 7.8 8.8 8.8 8.8 8.8 8.8 8.8 8.8 8.7 8.6 8.6 8.6 8.6 8.5 8.4 8.3 8.1 8.0 7.8 7.8 32
-0.1 -0.2 -3.1 -0.1 -0.2 -0.4 -4.6 -0.1 -0.3 -52 -5.3 -0.8 -0.1 -0.1 -6.3 -0.3 -0.2 -0.1 -43 -30 -0.1 -0.1 -56 -0.5 -0.1 -25 -62 -212 -111 -4.9 -11 -20 -154 -185 -154 -294 -205 -168 -86 -16 -476
– – – – – – – – – – – – – – – – – – – – – – – – -57 -51 -1.9 -1.9 -467 – – – -711 -0.8 -0.1 -0.1 -0.1 -0.4 0.0 0.0 -0.4
60 -62 -16 -2.6 -16 817 13 -26 -109 -57 5.2 226 170 -251 -25 -96 -156 73 583 -258 2,755 -139 -165 -355 -66 -77 -113 -228 -586 -20 -35 -26 -874 -193 -164 -302 -215 -176 -89 -23 -503
64 48 -71 328 93 -507 -21 -17 -11 14 -29 16 243 -204 3.3 25 38 144 588 -264 -238 130 51 -309 54 54 1,798 -935 -195 -224 85 250 -19 -66 -26 -146 -60 -13 -59 163 30
65 141 48 43 48 111 -37 56 72 127 -30 30 90 192 40 122 191 462 459 267 289 303 256 78 147 113 43 -149 -56 172 130 137 126 150 112 115 120 163 95 181 559

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?